| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/23/2006 | WO2006031786A2 Protein a compositions and methods of use |
| 03/23/2006 | WO2006031653A2 Humanized anti-5t4 antibodies and anti-5t4 antibody / calicheamicin conjugates |
| 03/23/2006 | WO2006031337A2 Combinations of pkc activators and pkc inhibitors for alzheimer’s disease treatment and cognitive enhancement |
| 03/23/2006 | WO2006030947A1 Joint use of sulfonamide based compound with angiogenesis inhibitor |
| 03/23/2006 | WO2006030941A1 Simultaneous use of sulfonamide-containing compound and angiogenesis inhibitor |
| 03/23/2006 | WO2006030826A1 Medicinal composition |
| 03/23/2006 | WO2006030750A1 Extract from agaricus blazei murrill capable of inhibiting breast cancer |
| 03/23/2006 | WO2006029863A1 Thiazolinone 2-substituted quinolines |
| 03/23/2006 | WO2006029862A1 Substituted hydantoins for the treatment of cancer |
| 03/23/2006 | WO2006029861A1 Thiazolinone 4-monosubstituted quinolines |
| 03/23/2006 | WO2006029579A1 Oral pharmaceutical composition for targeted transport of a platinum complex into the colorectal region, method for producing and use as medicament thereof |
| 03/23/2006 | WO2006029554A1 Vascular embolus of paclitaxel-sodium alginate microsphere and its preparation |
| 03/23/2006 | WO2006029497A1 Cancerous disease modifying antibodies |
| 03/23/2006 | WO2006029492A1 Kunitz-type recombinant inhibitor. |
| 03/23/2006 | WO2006029487A2 Platelet factor 4 variant 1 (pf4var1) related inhibitors of angiogenesis |
| 03/23/2006 | WO2006001954A3 Methods for promoting the formation of platelets and for treating blood and bone marrow disorders |
| 03/23/2006 | WO2005118584A3 Saframycin analogs as therapeutic agents in the treatment of cancer |
| 03/23/2006 | WO2005108355A3 Dihydrobenzothiophenes |
| 03/23/2006 | WO2005046658A3 Methods of modulating angiogenesis and cancer cell proliferation |
| 03/23/2006 | WO2005042743A3 Humanization of antibodies |
| 03/23/2006 | WO2005014577A9 Novel farnesyl protein transferase inhibitors as antitumor agents |
| 03/23/2006 | US20060063944 Estrone derivatives and process for producing same |
| 03/23/2006 | US20060063942 Mitotic kinesin inhibitors |
| 03/23/2006 | US20060063940 3-(arylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 03/23/2006 | US20060063935 (4S)-3-((E)-2-butenoyl-4-benzyl-2-oxazolidinone;antocarcinogenic agent; controlling progression of cancer through metastasis in animal suffering from a colon, lung, or breast cancer; synergistic mixture with other chemotherapeutic agent or radiation |
| 03/23/2006 | US20060063843 Compounds for the treatment of inflammatory disorders |
| 03/23/2006 | US20060063815 Polymorphs of an epothilone analog |
| 03/23/2006 | US20060063809 Tri-substituted heteroaryls and methods of making and using the same |
| 03/23/2006 | US20060063801 Anticancer therapeutics; 3-(7-Methoxy-4-oxo-4H-1-benzopyran-2-yl)-1-phenyl-1H-1,4-dihydroquinolin-4-one |
| 03/23/2006 | US20060063800 Use of hydroxamic acid derivatives for the preparation of anti-tumour medicaments |
| 03/23/2006 | US20060063789 Aminobenzamide derivatives as glycogen synthase kinase 3 beta inhibitors |
| 03/23/2006 | US20060063787 Condensed imidazole derivatives |
| 03/23/2006 | US20060063782 3-Hetero arylmethoxy ! pyridines and their analogues as p38 map kinase inhibitors |
| 03/23/2006 | US20060063778 2(R)-Benzyloxymethyl-4-[4-(4-chloro-phenyl)-piperazin-1-yl]-N-hydroxy-3(S)-(4-methoxy-phenyl)-4-oxo-butyramide; inhibiting matrix metalloproteinase; immunosuppression; neuropathic pain |
| 03/23/2006 | US20060063770 Nitrogenous heterocyclic compounds |
| 03/23/2006 | US20060063763 Compounds and methods for modulating CXCR3 function |
| 03/23/2006 | US20060063760 Hydroxamic acids useful in the treatment of hyper-proliferative disorders |
| 03/23/2006 | US20060063759 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 03/23/2006 | US20060063748 Methods for treating psychosis associated with interferson-alpha therapy |
| 03/23/2006 | US20060063723 Pharmaceutical composition comprising esterol derivatives for use in cancer therapy |
| 03/23/2006 | US20060063704 Somatostatin-dopamine chimeric analogs |
| 03/23/2006 | US20060063699 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 03/23/2006 | US20060063152 Novel gene and protein encoded by the gene |
| 03/23/2006 | US20060062842 Method of administering a compound to multi-drug resistant cells |
| 03/23/2006 | US20060062807 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 03/23/2006 | US20060062802 Medicinal product |
| 03/23/2006 | US20060062798 Vaccines |
| 03/23/2006 | US20060062789 Immunoglobulins; lupus, rheumatoid arthritis, multiple sclerosis, myasthenia gravis, Hashimoto's disease, immunodeficiency syndrome, asthma, allergic disorders, AIDS, and proliferative disorders such as leukemia |
| 03/23/2006 | US20060062781 Specific ab1'-antibodies against tumour-associated antigen ca 125 |
| 03/23/2006 | US20060062777 Inhibit tumor growth, or metastasis by modifying protein-protein interactions involving certain amino acid sequences within matrix metalloproteinase 9 (MMP-9) |
| 03/23/2006 | US20060062771 Therapeutic autologous-cell delivery support system, financial system for use therewith, and method therefor |
| 03/23/2006 | US20060062766 Remedy for cancer |
| 03/23/2006 | DE19826517B4 Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette Process for the preparation of film-coated tablets with cyclophosphamide as active ingredient and cyclophosphamide film-coated tablet prepared therefrom |
| 03/23/2006 | DE102004045720A1 Stabile Dosierungsform von Phenylalanin-Derivaten Stable dosage form of phenylalanine derivatives |
| 03/23/2006 | DE102004043153A1 Erfindung betreffend GLP-1 und Exendin Invention concerning GLP-1 and exendin |
| 03/23/2006 | DE102004036907A1 Use of a 5-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor for the production of an agent to treat or prevent hyper plastic and/or dysplastic large intestine polyps |
| 03/23/2006 | CA2580979A1 Novel compounds useful for modulating abnormal cell proliferation |
| 03/23/2006 | CA2580601A1 Novel compounds useful for modulating abnormal cell proliferation |
| 03/23/2006 | CA2580517A1 Protein a compositions and methods of use |
| 03/23/2006 | CA2579900A1 Cancerous disease modifying antibodies |
| 03/23/2006 | CA2579476A1 Thiazolinone 4-monosubstituted quinolines |
| 03/23/2006 | CA2579348A1 Thiazolinone 2-substituted quinolines |
| 03/23/2006 | CA2579130A1 Substituted hydantoins for the treatment of cancer |
| 03/23/2006 | CA2578131A1 Humanized anti-5t4 antibodies and anti-5t4 antibody/calicheamicin conjugates |
| 03/23/2006 | CA2577133A1 Polypeptide variants with altered effector function |
| 03/23/2006 | CA2575788A1 Combination of pkc activators and pkc inhibitors for alzheimer's diseasetreatment and cognitive enhancement |
| 03/22/2006 | EP1637611A1 Method for producing oligosaccharides |
| 03/22/2006 | EP1637608A2 Recombinant adenoviral vector and methods of use |
| 03/22/2006 | EP1637598A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody |
| 03/22/2006 | EP1637591A1 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survivial of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoc |
| 03/22/2006 | EP1637533A1 Substituted thiazolopyrimidines as analgetics |
| 03/22/2006 | EP1637529A1 Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of T-cell proliferation and uses thereof |
| 03/22/2006 | EP1637521A1 Novel tricyclic heterocycle compound |
| 03/22/2006 | EP1637160A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 03/22/2006 | EP1637148A1 Novel therapeutic use of polypodium extracts |
| 03/22/2006 | EP1637146A2 Ex vivo treatment of allogeneic and xenogeneic T-cells with gp39 antagonists |
| 03/22/2006 | EP1637140A1 Use of diphenylmethylpiperazine derivatives for the manufacture of a medicament for suppressing the proliferation of fibroblasts |
| 03/22/2006 | EP1637139A2 Novel use of HIV protease inhibiting compounds |
| 03/22/2006 | EP1636345A2 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 03/22/2006 | EP1636334A2 Recombinant anti-cd30 antibodies and uses thereof |
| 03/22/2006 | EP1636249A1 Target-oriented chemotherapy for treating tumors of the sexual organs |
| 03/22/2006 | EP1636238A1 Heteroryl-fused pyrimidinyl compounds as anticancer agents |
| 03/22/2006 | EP1636236A1 Pyrazolo-quinazoline derivatives,process for their preparation and their use as kinase inhibitors |
| 03/22/2006 | EP1636228A1 Novel pyridopyrazines and use thereof as kinase modulators |
| 03/22/2006 | EP1636227A1 Pyrimidine derivatives possessing cell-cycle inhibitory activity |
| 03/22/2006 | EP1636225A2 Pyridino 1,2-a pyrimidin-4-one compounds as anticancer agents |
| 03/22/2006 | EP1636213A1 3-aryloxy and 3-heteroaryloxy substituted benzo(b) thiophenes as therapeutic agents with pi3k activity |
| 03/22/2006 | EP1636212A1 Cycloalkylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
| 03/22/2006 | EP1636211A1 3-arylsulfanyl and 3-heteroarylsulfanyl substituted benzo[b]thiophenes as therapeutic agents |
| 03/22/2006 | EP1636198A1 Aniline derivatives |
| 03/22/2006 | EP1636195A1 Quinazolines and pyrido[3,4-d]pyrimidines as receptor tyrosine kinase inhibitors |
| 03/22/2006 | EP1636192A1 3-alkylidenehydrazino substituted heteroaryl compounds as thrombopoietin receptor activators |
| 03/22/2006 | EP1636186A1 2-hydroxymethyl-3,4,5-trihydroxy-1benzylpiperidine derivatives as inhibitors of glucosylceramide synthase (gcs) |
| 03/22/2006 | EP1636182A2 Prodrugs of mitotic kinesin inhibitors |
| 03/22/2006 | EP1635877A2 Specific high-relaxivity conjugate compounds for magnetic resonance imaging |
| 03/22/2006 | EP1635874A1 Compositions for oral administration of campothecin and its analogs |
| 03/22/2006 | EP1635862A1 Peptides derived from the protein mmp-2, and the use thereof in antitumoral immunotherapy |
| 03/22/2006 | EP1635856A2 Saposin c-dops: a novel anti-tumor agent |
| 03/22/2006 | EP1635849A1 Medicament for internal application, in particular against cancerous diseases |
| 03/22/2006 | EP1635840A1 Thiophenepyrimidinones as 17-beta-hydroxysteroid dehydrogenase inhibitors |